Biosimilars Market - PowerPoint PPT Presentation

About This Presentation
Title:

Biosimilars Market

Description:

Biosimilars market is expected to grow from US$ 18,435.89 million in 2021 to US$ 136,069.53 million by 2028; it is estimated to record a CAGR of 34.8% from 2022 to 2028 Read More: – PowerPoint PPT presentation

Number of Views:0
Slides: 9
Provided by: savnipandit
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Biosimilars Market


1
Biosimilars Market Forecast to 2028
US 136,069.53 Million
COVID-19 Impact and Global Analysis
Grow at a 34.8 CAGR from 20222028
Disease Indication (Cancer, Diabetes, Autoimmune
Diseases, and Other Diseases)
End User (Hospitals, Speciality Clinics,
Homecare, and Others)
US 18,435.89 Million
2021
2028
2
Table of Content
Biosimilars Market Geographic Analysis
Biosimilars Market Landscape
Biosimilars Market - Covid-19 Impact Analysis
Biosimilars Market Key Market Dynamics
Biosimilars Global Market Analysis
Industry Landscape
Global Biosimilars Market Analysis By Product
Company Profiles
3
Global Biosimilars Market has been Segmented as
Mentioned Below
By Drug Class
  • Cancer
  • Diabetes
  • Autoimmune Diseases
  • Other Diseases

4
Report Progress
Download Research Sample Pages _at_
https//www.theinsightpartners.com/sample/TIPHE100
001246/
5
The List of Companies - Biosimilars Market
  • Biocon Ltd
  • Sanofi-Aventis
  • Celltrion Inc.
  • Amgen Inc.
  • Pfizer Inc.
  • Samsung Bioepis
  • Sanofi SA
  • Coherus BioSciences Inc
  • Dr. Reddys Laboratories Ltd
  • Eli Lilly and Co
  • Sandoz AG
  • Teva Pharmaceutical Industries Ltd.

6
Frequently Asked Questions
What are reasons behind biosimilars market growth?
What are market opportunities for biosimilars
market?
Which type of biosimilars is expected to dominate
the market in the forecast period?
Which sector is expected to dominate the market
in the forecast period ?
What trends are expected to drive the demand for
various biosimilars?
Get all Answers _at_ https//www.theinsightpartners.c
om/reports/biosimilars-market
7
Reasons To Buy This Report
  • Highlights key business priorities to assist
    companies realign their business strategies.
  • Features key findings and crucial progressive
    industry trends in the global biosimilars market,
    thereby allowing players to develop effective
    long-term strategies.
  • Develops/modifies business expansion plans by
    using substantial growth offering from developed
    and emerging markets.
  • Scrutinizes in-depth market trends as well as key
    market drivers and restraints.
  • Enhances the decision-making process by
    understanding the strategies that underpin
    commercial interest with respect to products,
    segmentation, and industry verticals.

Buy This Report _at_ https//www.theinsightpartners.c
om/buy/TIPHE100001246/
8
Contact Us for More Details
Write a Comment
User Comments (0)
About PowerShow.com